2-[3-[4-(1-benzothiophen-2-yl)phenyl]-5-(4-pyrimidin-2-ylphenyl)phenyl]-4,6-diphenyl-1,3,5-triazine
C45H29N5S — CID 163807686
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[3-[4-(1-benzothiophen-2-yl)phenyl]-5-(4-pyrimidin-2-ylphenyl)phenyl]-4,6-diphenyl-1,3,5-triazine
2-[3-[4-(1-benzothiophen-2-yl)phenyl]-5-(4-pyrimidin-2-ylphenyl)phenyl]-4,6-diphenyl-1,3,5-triazine (PubChem CID 163807686) has the molecular formula C45H29N5S and a molecular weight of 671.83 g/mol. Its IUPAC name is 2-[3-[4-(1-benzothiophen-2-yl)phenyl]-5-(4-pyrimidin-2-ylphenyl)phenyl]-4,6-diphenyl-1,3,5-triazine.
Molecular Properties
| Compound Name | 2-[3-[4-(1-benzothiophen-2-yl)phenyl]-5-(4-pyrimidin-2-ylphenyl)phenyl]-4,6-diphenyl-1,3,5-triazine |
|---|---|
| PubChem CID | 163807686 |
| Molecular Formula | C45H29N5S |
| Molecular Weight | 671.83 g/mol |
| Exact Mass | 671.21 |
| IUPAC Name | 2-[3-[4-(1-benzothiophen-2-yl)phenyl]-5-(4-pyrimidin-2-ylphenyl)phenyl]-4,6-diphenyl-1,3,5-triazine |
| SMILES | c1ccc(-c2nc(-c3ccccc3)nc(-c3cc(-c4ccc(-c5ncccn5)cc4)cc(-c4ccc(-c5cc6ccccc6s5)cc4)c3)n2)cc1 |
| InChI | InChI=1S/C45H29N5S/c1-3-10-33(11-4-1)43-48-44(34-12-5-2-6-13-34)50-45(49-43)39-27-37(26-38(28-39)31-18-22-35(23-19-31)42-46-24-9-25-47-42)30-16-20-32(21-17-30)41-29-36-14-7-8-15-40(36)51-41/h1-29H |
| InChIKey | NKLIXAMEUIFXQL-UHFFFAOYSA-N |
| XLogP | 11.55 |
| TPSA | 64.45 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 51 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 671.83 |
| LogP ≤ 5 | 11.55 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163807686 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.